(Q53594785)

16 May 2018

title

Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice. (English)

1 reference

16 May 2018

0 references

1 reference

Eugene N Bush

1

1 reference

16 May 2018

Robin Shapiro

2

1 reference

16 May 2018

Michael E Brune

3

1 reference

16 May 2018

Victoria E Knourek-Segel

4

1 reference

16 May 2018

Brian A Droz

5

1 reference

16 May 2018

Thomas Fey

6

1 reference

16 May 2018

Emily Lin

7

1 reference

16 May 2018

Peer B Jacobson

8

1 reference

16 May 2018

publication date

1 April 2006

1 reference

16 May 2018

published in

Endocrine

1 reference

16 May 2018

volume

29

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

375-381

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1385/endo:29:2:375

exact match

0 references

cites work

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

1 reference

12 December 2020

Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice

1 reference

12 December 2020

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

1 reference

12 December 2020

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Pharmacologic induction of weight loss to treat type 2 diabetes.

1 reference

12 December 2020

Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity

1 reference

12 December 2020

Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa

1 reference

12 December 2020

Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist

1 reference

12 December 2020

Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats

1 reference

12 December 2020

Appetite suppressants and valvular heart disease - a systematic review

1 reference

12 December 2020

A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control.

1 reference

12 December 2020

Circulating ghrelin levels are decreased in human obesity.

1 reference

12 December 2020

Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice

1 reference

12 December 2020

Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

1 reference

12 December 2020

Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry

1 reference

12 December 2020

Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition

1 reference

12 December 2020

Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines

1 reference

12 December 2020

Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet

1 reference

12 December 2020

Validation and calibration of DEXA body composition in mice

1 reference

12 December 2020

Neuroendocrine regulation of growth hormone.

1 reference

12 December 2020

The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people

1 reference

12 December 2020

The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis

1 reference

12 December 2020

Reversal of diet-induced obesity and diabetes in C57BL/6J mice.

1 reference

12 December 2020

Activation of central melanocortin pathways by fenfluramine

1 reference

12 December 2020

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

1 reference

12 December 2020

Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine

1 reference

12 December 2020

Effects of growth hormone and prolactin on adipose tissue development and function

1 reference

12 December 2020

Identifiers

DOI

10.1385/ENDO:29:2:375

1 reference

16 May 2018

Dimensions Publication ID

1044765095

0 references

1 reference

16 May 2018